Living longer is only part of the ageing story. Increasingly, the focus is moving towards how many of those years are spent in good health. Lifespan refers to the total number of years a person lives. Healthspan refers to the years spent in relatively good physical and mental health, with fewer serious limitations caused by disease, pain or loss of independence.
Longer life does not always mean healthier life. People may live for many years while managing chronic conditions that affect mobility, independence and overall quality of life. As a result, healthy ageing is becoming less about extending life alone and more about extending the period of life spent in good health.
This shift has wider relevance as ageing populations increase demand for healthcare, prevention, monitoring and long-term support. It also places more attention on the factors that can influence health over time.
Genetics remains part of the picture, but lifestyle and environment can also play an important role. Regular physical activity, a balanced diet, good sleep, avoiding tobacco and maintaining social connections can all support healthier ageing. Preventive healthcare, including routine checks and appropriate screening, can also help identify potential problems earlier.
Managing common health risks is another important part of maintaining healthspan. Blood pressure, cholesterol, blood sugar and body weight can influence the risk of developing conditions that become more common with age. Addressing these areas earlier may help reduce the impact of disease later in life.
Physical strength and mobility are particularly important. Maintaining muscle, balance and cardiovascular fitness can support independence and reduce the likelihood that everyday activities become more difficult with age.
Mental and social wellbeing also contribute to healthy ageing. Staying connected with other people, remaining mentally active and managing stress can support overall health alongside more traditional medical measures.
Genflow Biosciences plc (LON:GENF, OTCQB:GENFF, FRA:WQ5) is a UK-based biotech firm with R&D facilities in Belgium focused on developing novel therapeutic approaches that potentially halt or slow the aging process in humans and dogs supporting longer, healthier lives
